BENJAMIN R. YERXA - 02 Mar 2022 Form 3 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
02 Mar 2022
Transactions value $
$0
Form type
3
Filing time
04 Mar 2022, 15:56:10 UTC
Next filing
24 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLSD Common Stock 10.1K 02 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney